Douglas Godshall Net Worth

The estimated Net Worth of Douglas Evan Godshall is at least 75.7 百万$ dollars as of 15 February 2024. Mr. Godshall owns over 10,000 units of Shockwave Medical stock worth over 57,832,080$ and over the last 10 years he sold SWAV stock worth over 15,666,581$. In addition, he makes 2,208,320$ as President、 Chief Executive Officer、 Director at Shockwave Medical.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Godshall SWAV stock SEC Form 4 insiders trading

Douglas has made over 33 trades of the Shockwave Medical stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of SWAV stock worth 34,200$ on 15 February 2024.

The largest trade he's ever made was exercising 280,000 units of Shockwave Medical stock on 16 November 2020 worth over 957,600$. On average, Douglas trades about 15,854 units every 33 days since 2014. As of 15 February 2024 he still owns at least 172,762 units of Shockwave Medical stock.

You can see the complete history of Mr. Godshall stock trades at the bottom of the page.

Douglas Godshall biography

Douglas Evan Godshall serves as President, Chief Executive Officer, Director of the Company. Previously, Mr. Godshall served as the Chief Executive Officer of HeartWare International, Inc. (“HeartWare”), a Nasdaq-listed company, from September 2006 until August 2016 and as director from October 2006 until its acquisition by Medtronic plc in August 2016. Prior to joining HeartWare, Mr. Godshall served in various executive, managerial and leadership positions at Boston Scientific Corporation (“Boston Scientific”), where he had been employed since 1990. Mr. Godshall also serves on the board of directors of Eyepoint Pharmaceuticals, Inc. Mr. Godshall has a B.A. in Business from Lafayette College and M.B.A from Northeastern University.

What is the salary of Douglas Godshall?

As the President、 Chief Executive Officer、 Director of Shockwave Medical, the total compensation of Douglas Godshall at Shockwave Medical is 2,208,320$. There are no executives at Shockwave Medical getting paid more.

How old is Douglas Godshall?

Douglas Godshall is 55, he's been the President、 Chief Executive Officer、 Director of Shockwave Medical since 2017. There are 7 older and 8 younger executives at Shockwave Medical. The oldest executive at Shockwave Medical Inc. is John M. Adams, 74, who is the Co-Founder and Technical Advisor.

What's Douglas Godshall's mailing address?

Douglas's mailing address filed with the SEC is C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA, CA, 95054.

Insiders trading at Shockwave Medical

Over the last 6 years, insiders at Shockwave Medical have traded over 488,603,927$ worth of Shockwave Medical stock and bought 30,000 units worth 510,000$ . The most active insiders traders include James E Deerfield Mgmt L.P....、Antoine Papiernik、Capital Vii Fcpr Sofinnova. On average, Shockwave Medical executives and independent directors trade stock every 8 days with the average trade being worth of 10,693,924$. The most recent stock trade was executed by Trinh Phung on 17 May 2024, trading 19,763 units of SWAV stock currently worth 121,740$.

What does Shockwave Medical do?

shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen

Complete history of Mr. Godshall stock trades at EyePoint Pharmaceuticals Inc、Shockwave Medical

Shockwave Medical executives and stock owners

Shockwave Medical executives and other stock owners filed with the SEC include:

• Douglas Godshall,
  President, Chief Executive Officer, Director
• Daniel Puckett,
  Chief Financial Officer
• Douglas E. Godshall,
  Pres, CEO & Director
• Isaac Zacharias,
  Chief commercial Officer
• Isaac Zacharias,
  Chief Commercial Officer
• Daniel Puckett MBA,
  CFO, Principal Financial Officer & Sec.
• Colin Cahill,
  Independent Director
• F. Thomas Watkins,
  Independent Director
• Antoine Papiernik,
  Independent Director
• Frederic Moll,
  Independent Director
• C. Raymond Larkin,
  Independent Chairman of the board
• Laura Francis,
  Independent Director
• Maria Sainz,
  Director
• Trinh Phung,
  Chief Accounting Officer, Principal Accounting Officer & VP of Fin.
• Robert Fletcher,
  VP of Marketing
• Rob Williamson Jr.,
  VP of Sales
• Hajime Tada J.D.,
  Gen. Counsel & Sec.
• Debbie Kaster,
  Head of Investor Relations
• Mike Maszy,
  VP of Operations
• John M. Adams,
  Co-Founder and Technical Advisor
• Daniel Hawkins,
  Founder and Sr. Advisor
• Sara Toyloy,
  Director
• Capital Vii Fcpr Sofinnova,
  10% owner
• James E Deerfield Mgmt L.P....,
  
• Dan Puckett,
  Chief Financial Officer
• Associates Vii, L.P.Venrock...,
  
• Trinh Phung,
  SVP, Finance
• Kevin J. Ballinger,
  Director
• Renee Gaeta,
  Chief Financial Officer